Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning.
- 1 July 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 86 (1) , 311-319
- https://doi.org/10.1161/01.cir.86.1.311
Abstract
BACKGROUND Several recent studies suggest that activation of ATP-dependent potassium (K(ATP)) channels in the myocardium plays an important cardioprotective role during ischemia. The present study was undertaken to examine further the role of this ion channel in vivo in a model of "stunned" myocardium. METHODS AND RESULTS Barbital-anesthetized dogs were subjected to 15 minutes of left anterior descending (LAD) coronary artery occlusion followed by 3 hours of reperfusion. Regional myocardial blood flow was measured by radioactive microspheres and segment function by sonomicrometry. Intravenous administration of the potassium channel opener aprikalim (RP 52891) at a dose that produced no significant systemic hemodynamic effects (10 micrograms/kg plus 0.1 microgram/kg/min) resulted in a marked improvement in segment shortening in the ischemic/reperfused myocardium compared with control animals (p less than 0.05) when given before the ischemic insult. However, administration of aprikalim immediately before reperfusion had no beneficial effect. Furthermore, pretreatment with the K(ATP) channel antagonist glibenclamide antagonized the recovery of contractile function afforded by aprikalim when administered at a low dose (0.3 mg/kg) that alone had no effect on postischemic recovery. In contrast, pretreatment with either a higher dose of glibenclamide (1.0 mg/kg) or the related sulfonylurea K(ATP) channel antagonist tolbutamide (100 mg/kg) resulted in a worsening of segment function after reperfusion. The ability of aprikalim and the K(ATP) channel antagonists to alter postischemic wall function occurred independently of differences in systemic hemodynamics, area at risk, and collateral blood flow during occlusion, the major determinants of the extent of myocardial stunning. CONCLUSIONS These results suggest that opening myocardial K(ATP) channels in the ischemic heart results in a marked cardioprotective effect in stunned myocardium and that these channels may serve an endogenous function, which is to provide protection from ischemic insults.Keywords
This publication has 25 references indexed in Scilit:
- Calcium and ischemic injuryTrends in Cardiovascular Medicine, 1991
- Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective propertiesLife Sciences, 1990
- Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: A potential new approach to the management of ischemia-induced malignant ventricular arrhythmiasAmerican Heart Journal, 1990
- Nicorandil Improves postischemic Contractile function Independently of Direct Mycardial.EffectsJournal of Cardiovascular Pharmacology, 1990
- Hypoxic Dilation of Coronary Arteries Is Mediated by ATP-Sensitive Potassium ChannelsScience, 1990
- Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1990
- The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogsCardiovascular Drugs and Therapy, 1990
- Effects of Pinacidil on Myocardial Blood Flow and Infarct Size After Acute Left Anterior Descending Coronary Artery Occlusion and Reperfusion in Awake Dogs With and Without a Coexisting Left Circumflex Coronary Artery StenosisJournal of Cardiovascular Pharmacology, 1989
- Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosisAmerican Heart Journal, 1988
- Comparison of the effects of pinacidil and its metabolite, pinacidil-N-oxide, in isolated smooth and cardiac muscleDrug Development Research, 1986